Press Releases

 
Jul July 21, 2016

Study Demonstrates Cardiac Troponin Analysis Can Help Identify Heart Disease Risk and Guide Treatment

Jul July 5, 2016

Singulex enters into World-Wide Service Agreement with Tecan

May May 31, 2016

Singulex Announces a $50 Million Investment by Grifols for a 20% Stake in the Company

Nov November 12, 2015

US Patent Awarded to Singulex for Expanded Use of Biomarkers Troponin I and T to Detect Cardiac Health Status with Single-Molecule Methods

Nov November 5, 2015

Singulex Receives European Patent Expanding Use of Biomarkers Troponin I and T to Detect Cardiac Health Status with High-Sensitivity Methods

Jul July 14, 2015

Singulex Demonstrates Ultrasensitive “Sgx ClarityTM System” at AACC 2015

May May 21, 2015

Singulex Announces EMD Millipore to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive Single Molecule Counting (SMCTM) Technology

Apr April 30, 2015

Singulex Announces Partnership with The Dutch Technology Foundation (STW) to Accelerate the Development of Clinical Biomarkers

Apr April 28, 2015

Singulex Key Patent Granted in Japan for Detecting or Monitoring Cardiovascular Disease Using Proprietary Biomarkers

Apr April 9, 2015

Singulex Announces Collaboration with CHDI Foundation to Develop Biomarker Assays for Huntington’s Disease